Market Overview

American Shared Hospital Services Announces Proposed 2019 CMS Proton Therapy and Gamma Knife Reimbursement Rates

Share:

Increases of around 2.6% for Proton Therapy and 2.9% for Gamma Knife
Proposed

American Shared Hospital Services (NYSE:AMS) (the "Company"),
a leading provider of turnkey technology solutions for advanced
radiosurgical and radiation therapy services, announced today that the
Centers for Medicare and Medicaid Services (CMS) has posted its proposed
Medicare hospital outpatient prospective payment rates for calendar year
2019.

CMS's proposed 2019 proton therapy delivery code rates per daily session
are $530.43, a 1.6% increase ($522.31 in 2018) for a simple treatment
without compensation, and $1,081.08, a 2.6% increase ($1,053.52 in 2018)
for a simple treatment with compensation, or an intermediate or a
complex treatment.

Also, CMS is proposing a 2.9% increase in the comprehensive
reimbursement rate for the Gamma Knife in 2019.

CMS will accept comments on these proposals until September 24, 2018 and
will publish final rates in late 2018 to be effective January 1, 2019.

About AMS:

American Shared Hospital Services provides turnkey technology solutions
for advanced radiosurgical and radiation therapy services. AMS is the
world leader in providing Gamma Knife radiosurgery equipment, a
non-invasive treatment for malignant and benign brain tumors, vascular
malformations and trigeminal neuralgia (facial pain). The Company also
offers proton therapy, and the latest IGRT and IMRT systems.

Safe Harbor Statement:

This press release may be deemed to contain certain forward-looking
statements with respect to the financial condition, results of
operations and future plans of American Shared Hospital Services
(including statements regarding the expected continued growth in volume
of the MEVION S250 system, the expansion of the Company's proton therapy
business, and the timing of treatments by new Gamma Knife systems) which
involve risks and uncertainties including, but not limited to, the risks
of variability of financial results between quarters, the risks of the
Gamma Knife and radiation therapy businesses, the risks of developing
The Operating Room for the 21st Century program, and the risks of the
timing, financing, and operations of the Company's proton therapy
business. Further information on potential factors that could affect the
financial condition, results of operations and future plans of American
Shared Hospital Services is included in the filings of the Company with
the Securities and Exchange Commission, including the Company's Annual
Report on Form 10-K for the year ended December 31, 2017, its quarterly
report on Form 10-Q for the three months ended March 31, 2018 and the
definitive Proxy Statement for the Annual Meeting of Shareholders held
on June 14, 2018.

View Comments and Join the Discussion!